Extrawell Pharmaceutical Holdings LtdExtrawell Pharmaceutical Holdings Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

If you are employed by Extrawell Pharmaceutical Holdings Ltd and you would like to licence your Sustainability aseessment, please get in touch. Jump to the bottom of the webpage for potential risks for Extrawell Pharmaceutical Holdings Ltd based on sector, geography and size. This ESG score includes 17 UN SDGs including: 'No Poverty', 'Climate Action' and 'Life below Water'.

Extrawell Pharmaceutical Holdings Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.9; made up of an environmental score of 8.0, social score of 4.8 and governance score of 8.0.

SDG Transparency Score for Extrawell Pharmaceutical Holdings Ltd 
Low
0 - 3

6.9

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Extrawell Pharmaceutical Holdings Ltd 
8.0

Environmental

4.8

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
355Xbrane Biopharma AB
7.0
High
355Xenetic Biosciences Inc
7.0
High
387Extrawell Pharmaceutical Holdings Ltd
6.9
High
387Advanced Medical Solutions Group PLC
6.9
High
387Acrux Ltd
6.9
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Extrawell Pharmaceutical Holdings Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd offer flexible work?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose water use targets?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Extrawell Pharmaceutical Holdings Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Extrawell Pharmaceutical Holdings Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Extrawell Pharmaceutical Holdings Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Extrawell Pharmaceutical Holdings Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Extrawell Pharmaceutical Holdings Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Extrawell Pharmaceutical Holdings Ltd
These potential risks are based on the size, segment and geographies of the company.

Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, distributes, and sells pharmaceutical products in the People's Republic of China. The company operates through Manufacturing, Trading, and Gene Development segments. It offers transfer factor oral solution, a dual immune regulator for the treatment of diseases caused by virus infection and weak cellular immune system; and Wisk for the treatment of II-III degree of radio-injury of skin, normal common burn, actinic dermatitis, various infectious ulcers, and oral ulcers, as well as for trauma and post operation wound healing. The company also provides ZhouBang, a thromboxane synthetase inhibitor to prevent the coagulation of platelets and facilitate relaxation of blood vessels. In addition, it is involved in the marketing and distribution of imported pharmaceutical products, including Millibar for the treatment of high blood pressure; and development of oral insulin. Further, the company engages in the commercial exploitation and development of genome-related technology; provision of agency services; property investment business; and holding of gene invention rights. Extrawell Pharmaceutical Holdings Limited is headquartered in Quarry Bay, Hong Kong.

Sorry!

Failed to process!